Legal

• Official Reply on the Issue of the Effectiveness of the Agreements of Hong Kong and Macao-Invested Enterprises Registered and Established in the Guangdong–Hong Kong–Macao Greater Bay Area in Which the Laws of Hong Kong or Macao are Selected as the Laws Governing the Contract or that Specify Hong Kong or Macao as the Seat of Arbitration

  关于在粤港澳大湾区内地登记设立的香港、澳门投资企业协议选择港澳法律为合同适用法律或者协议约定港澳为仲裁地效力问题的批复

  SPC clarifies on the contract governing law in Hong Kong and Macao investments in the Greater Bay Area / CLP Reference: 1450/25.02.13 ; Promulgated: 2025-02-13 ; Effective: 2025-02-14

  March 10, 2025

• In the News: CSRC Increases Scrutiny of Chinese IPOs in the US; China Issues New Rules on Personal Information Audits; and First Major US AI Copyright Ruling

  China clamps down on small-cap U.S. listings by Chinese issuers; China mandates personal information protection compliance audits for companies; and AI company loses against Reuters in U.S. summary judgment with key implication

  March 07, 2025

  

• Legislation roundup: Pharma monopoly concentrations, online trading data compliance, and GBA contract governing laws

  State Council defines concentrations of business operators of the pharmaceutical sector. Network trading platform operators are required to submit information on the identities of online trading business operators. SPC clarifies on the contract governing law in Hong Kong and Macao investments in the Greater Bay Area.

  February 28, 2025

• 2024 Annual Review and 2025 Outlook for TMT Regulation in China

  Philip Qu of TransAsia Lawyers analyze regulatory and statutory progress in China’s ever flourishing TMT sector in 2024, and look at the outlook for 2025

  February 27, 2025

  

• In the News: America First Policy; Overseas Crypto Investment Not Protected in China; and China Offshore Fundraising

  Trump signs memorandum to restrict investments that do not serve American interests; A Jiangsu court ruled that investments in overseas crypto projects are not protected under Chinese law; and Chinese companies raise funds in hope of easing of regulations against private enterprises

  February 27, 2025

  

• Annual Review of Intellectual Property Legislation and Judicial Practices in 2024

  2024 marked another significant year in China’s intellectual property law space. Danlei Wu of Fangda Partners examines the key developments and the indicators for further developments in the year ahead

  February 27, 2025

  

• National Financial Regulatory Administration, Measures for the Regulatory Rating of Insurance Companies

  国家金融监督管理总局保险公司监管评级办法

  Regulatory ratings of insurance companies include corporate governance, solvency, liability quality and asset quality / CLP Reference: 3910/25.01.07 ; Issued: 2025-01-07 ; Effective: 2025-03-01

  February 26, 2025

• General Office of the Ministry of Industry and Information Technology, Circular on Strengthening the Protection of the Security of Customer Data by Internet Data Centers

  工业和信息化部办公厅关于加强互联网数据中心客户数据安全保护的通知

  Data centers are required to safeguard the security of the customer’s own training datasets / Issued: 2025-01-13

  February 26, 2025

• Opinions on the Application of Securities and Futures Laws, No.19: Opinions on the Application of Articles 13 and 14 of the Measures for the Administration of the Takeover of Listed Companies

  证券期货法律适用意见第19号——《上市公司收购管理办法》第十三条、第十四条的适用意见

  CSRC clarifies on the shareholding changes in takeovers of listed companies. / CLP Reference: 3700/25.01.10 ; Issued: 2025-01-10 ; Effective: 2025-01-10

  February 26, 2025

• Regulatory Developments in the China Pharmaceutical and Medtech Sector in 2024, and the Outlook for 2025

  Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications

  February 26, 2025